METHODS OF TREATING OCULAR INFLAMMATORY DISEASES

The present invention relates to methods of treating ocular inflammatory diseases by administering ophthalmic pharmaceutical compositions of roflumilast. Administration of ophthalmic pharmaceutical compositions of roflumilast can provide significant immunomodulatory and anti-inflammatory activity re...

Full description

Saved in:
Bibliographic Details
Main Authors Hemmati, Houman David, Verhoeven, Rozemarijn, Gukasyan, Hovhannes John, Estes, Daniel J, Jeffords, Elizabeth W
Format Patent
LanguageEnglish
Published 23.03.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to methods of treating ocular inflammatory diseases by administering ophthalmic pharmaceutical compositions of roflumilast. Administration of ophthalmic pharmaceutical compositions of roflumilast can provide significant immunomodulatory and anti-inflammatory activity relative to existing immunomodulatory, immunosuppressant, or non-steroidal anti-inflammatory therapies, including corticosteroids and antihistamines, while also providing an improved safety and convenience profile relative to one or both agents.
Bibliography:Application Number: US202217950802